| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9154847 | American Heart Journal | 2005 | 7 Pages |
Abstract
Use of morphine either alone or in combination with nitroglycerin for patients presenting with NSTE ACS was associated with higher mortality even after risk adjustment and matching on propensity score for treatment. This analysis raises concerns regarding the safety of using morphine in patients with NSTE ACS and emphasizes the need for a randomized trial. (Am Heart J 2005;149:.)
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Trip J. MD, Matthew T. MD, MHS, Anita Y. MS, Manesh R. MD, Jeffrey B. PharmD, E. Magnus MD, W. Frank MD, Charles V. MD, MA, W. Brian MD, Eric D. MD, MPH, for the CRUSADE Investigators for the CRUSADE Investigators,